FI964253A0 - Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi - Google Patents

Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi

Info

Publication number
FI964253A0
FI964253A0 FI964253A FI964253A FI964253A0 FI 964253 A0 FI964253 A0 FI 964253A0 FI 964253 A FI964253 A FI 964253A FI 964253 A FI964253 A FI 964253A FI 964253 A0 FI964253 A0 FI 964253A0
Authority
FI
Finland
Prior art keywords
controlled release
active substances
collagen preparation
collagen
preparation
Prior art date
Application number
FI964253A
Other languages
English (en)
Swedish (sv)
Other versions
FI964253A (fi
FI118415B (fi
Inventor
Michael Roreger
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI964253A publication Critical patent/FI964253A/fi
Publication of FI964253A0 publication Critical patent/FI964253A0/fi
Application granted granted Critical
Publication of FI118415B publication Critical patent/FI118415B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI964253A 1994-04-27 1996-10-22 Kollageenivalmiste vaikuttavien aineiden säädellyksi vapautumiseksi FI118415B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4414755 1994-04-27
DE4414755A DE4414755C2 (de) 1994-04-27 1994-04-27 Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
EP9501428 1995-04-15
PCT/EP1995/001428 WO1995028964A1 (de) 1994-04-27 1995-04-15 Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen

Publications (3)

Publication Number Publication Date
FI964253A FI964253A (fi) 1996-10-22
FI964253A0 true FI964253A0 (fi) 1996-10-22
FI118415B FI118415B (fi) 2007-11-15

Family

ID=6516606

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964253A FI118415B (fi) 1994-04-27 1996-10-22 Kollageenivalmiste vaikuttavien aineiden säädellyksi vapautumiseksi

Country Status (21)

Country Link
US (1) US6761908B1 (fi)
EP (1) EP0804245B1 (fi)
JP (1) JP3865077B2 (fi)
KR (1) KR970702733A (fi)
AT (1) ATE180409T1 (fi)
AU (1) AU695621B2 (fi)
CZ (1) CZ291190B6 (fi)
DE (2) DE4414755C2 (fi)
DK (1) DK0804245T3 (fi)
ES (1) ES2134468T3 (fi)
FI (1) FI118415B (fi)
GR (1) GR3030955T3 (fi)
HU (1) HUT75468A (fi)
IL (1) IL113326A (fi)
MY (1) MY114090A (fi)
NO (1) NO309256B1 (fi)
NZ (1) NZ284476A (fi)
PL (1) PL179952B1 (fi)
SK (1) SK281461B6 (fi)
WO (1) WO1995028964A1 (fi)
ZA (1) ZA953410B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
WO1999017738A1 (en) 1997-10-03 1999-04-15 Lavipharm Laboratories, Inc. A prolamine-plant polar lipid composition, its method of preparation and applications thereof
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
DE19856668A1 (de) * 1998-12-09 2000-06-15 Aesculap Ag & Co Kg Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung
IT1317832B1 (it) * 2000-02-15 2003-07-15 Eurores S R L Procedimento per la preparazione di collagene micronizzato e sueapplicazioni terapeutiche.
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
FR2816847B1 (fr) * 2000-11-22 2006-07-14 Assist Publ Hopitaux De Paris Biomateriaux polymeriques poreux, procede de preparation et utilisations
EP1536746B1 (en) * 2002-06-24 2013-05-08 Incept, LLC Fillers and methods for displacing tissues to improve radiological outcomes
US20050032246A1 (en) * 2002-11-14 2005-02-10 Mcmaster University Method of immobilizing membrane-associated molecules
JP2005263785A (ja) * 2004-02-18 2005-09-29 Koken Co Ltd 溶解するフェイシャルマスク
DE102004022645A1 (de) * 2004-05-07 2005-12-15 Resorba Wundversorgung Gmbh & Co. Kg Bioresorbierbares Material auf Kollagen-Basis
JP2006191455A (ja) 2005-01-07 2006-07-20 Nec Corp 無線移動通信方法、無線移動通信システム、基地局制御装置及び無線移動端末
DE102005017845A1 (de) * 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptische Kollagenzubereitungen, ihre Verwendung und Verfahren zu ihrer Herstellung
JP4621563B2 (ja) * 2005-08-26 2011-01-26 新田ゼラチン株式会社 皮膚用保水シート
CA2559430A1 (en) * 2005-09-09 2007-03-09 Jodi Lastman Self-inflating nursing pillow and method of operating the same
EP3960215A1 (en) 2009-12-15 2022-03-02 Incept, LLC Implants and biodegradable fiducial markers
AU2011232414A1 (en) 2010-03-24 2012-11-15 Covidien Lp Combination three-dimensional surgical implant
US9347081B2 (en) 2011-04-19 2016-05-24 Bioiberica, S.A. Cartilage product
US10420818B2 (en) * 2014-05-08 2019-09-24 Wake Forest University Health Sciences Methods of treating incontinence and other sphincter deficiency disorders
DE102014108633B4 (de) 2014-06-18 2024-02-08 Kulzer Gmbh Vorrichtung und Verfahren zur Herstellung dreidimensionaler Objekte mittels Rapid-Prototyping
WO2020043665A1 (en) 2018-08-27 2020-03-05 Claudia Eder Antiseptic gel

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT71305B (de) * 1913-05-07 1916-03-10 Morton Lewis Johnson Fernsprechsystem.
GB1347582A (en) * 1972-02-02 1974-02-27 Interprinderea Flacara Rosie Collagenic medicinal dressing
US4021522A (en) 1973-09-10 1977-05-03 Collagen Products Pty. Limited Method of forming collagen dispersions
JPS597684B2 (ja) 1976-05-20 1984-02-20 明治製菓株式会社 コラ−ゲンを用いた眼用徐放性制御医薬剤
US4164559A (en) * 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
US4279812A (en) 1979-09-12 1981-07-21 Seton Company Process for preparing macromolecular biologically active collagen
DE2943520C2 (de) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
US4409332A (en) 1982-01-12 1983-10-11 Jefferies Steven R Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
IL74715A0 (en) 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
US4789663A (en) 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
CA1259914A (en) 1984-07-06 1989-09-26 Donald G. Wallace Methods of bone repair using collagen
DE3429038A1 (de) 1984-08-07 1986-02-20 B. Braun Melsungen Ag, 3508 Melsungen Wirkstoff-depot
US4563350A (en) 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
US5246457A (en) 1985-03-28 1993-09-21 Collagen Corporation Xenogeneic collagen/mineral preparations in bone repair
SE462894B (sv) * 1985-10-28 1990-09-17 Biogram Ab Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning
IT1181737B (it) 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
EP0302953A1 (de) * 1987-08-11 1989-02-15 Deutsche Gelatine-Fabriken Stoess AG Verfahren zur Herrstellung von Formkörpern aus Kollagen und Kollagenabbauprodukten
FR2619506B1 (fr) 1987-08-17 1990-08-24 Septodont Procede de fabrication de preparations medicamenteuses solides associant du collagene et un agent anti-infectieux imidazole, ainsi que leur application au traitement d'affections du parodonte
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
EP0326151B1 (en) * 1988-01-29 1993-06-16 Sumitomo Pharmaceuticals Company, Limited Improved controlled release formulation
US5219576A (en) * 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
DE3841397A1 (de) 1988-12-08 1990-06-21 Melzer Wolfgang Poroeser resorbierbarer arzneistofftraeger
ES2111566T3 (es) * 1990-04-24 1998-03-16 Mark Eisenberg Equivalentes compuestos de piel viva.
DE4028088A1 (de) * 1990-09-05 1992-04-16 Berg Ernes Elme Dipl Ing Resorbierbare kollagenimplantate
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
DE4038887A1 (de) * 1990-12-06 1992-07-02 Lohmann Therapie Syst Lts Verfahren zur herstellung von kollagenpartikeln und ihre verwendung als wirkstofftraeger
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
WO1992022304A1 (en) * 1991-06-14 1992-12-23 Amgen Inc. Collagen film drug delivery for proteins
ATE164761T1 (de) * 1991-07-09 1998-04-15 Vitaphore Corp Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung
US5259998A (en) * 1991-10-04 1993-11-09 Chiron Ophthalmics, Inc. Method for casting dissolvable ophthalmic shields in a mold
GB9206508D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Biopolymer composites

Also Published As

Publication number Publication date
FI964253A (fi) 1996-10-22
IL113326A0 (en) 1995-07-31
DE4414755A1 (de) 1996-01-11
NZ284476A (en) 1998-08-26
DE4414755C2 (de) 2000-11-16
AU2307895A (en) 1995-11-16
WO1995028964A1 (de) 1995-11-02
EP0804245A1 (de) 1997-11-05
DK0804245T3 (da) 1999-11-29
AU695621B2 (en) 1998-08-20
MY114090A (en) 2002-08-30
JPH09512257A (ja) 1997-12-09
ES2134468T3 (es) 1999-10-01
EP0804245B1 (de) 1999-05-26
HUT75468A (en) 1997-05-28
FI118415B (fi) 2007-11-15
JP3865077B2 (ja) 2007-01-10
SK138096A3 (en) 1997-08-06
SK281461B6 (sk) 2001-04-09
PL316659A1 (en) 1997-02-03
KR970702733A (ko) 1997-06-10
CZ310896A3 (en) 1997-06-11
PL179952B1 (en) 2000-11-30
CZ291190B6 (cs) 2003-01-15
HU9602948D0 (en) 1996-12-30
DE59506057D1 (de) 1999-07-01
NO964539D0 (no) 1996-10-25
ZA953410B (en) 1996-04-09
IL113326A (en) 2000-01-31
US6761908B1 (en) 2004-07-13
NO964539L (no) 1996-12-18
NO309256B1 (no) 2001-01-08
ATE180409T1 (de) 1999-06-15
GR3030955T3 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
FI964253A0 (fi) Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi
DE69008954D1 (de) Einsetzbares künstliches Schliessmuskelsystem.
DE69726229D1 (de) Prothese mit Flansch
DE3882126T2 (de) Künstliches Beatmungsgerät.
DE68909691D1 (de) Multischichtkörper zur Abgabe von Duftstoffen.
BR9306683A (pt) Adesivo proteináceo curado com aldeído
DE68912994T2 (de) Prothese.
NO891982L (no) Polymer-sammensetning.
NO900348L (no) Hybrid kunststoffmaterialer.
DE68917037D1 (de) System zur Stromversorgung.
DE68912588T2 (de) Eisenbahndrehgestell mit verbessertem stabilitäts- und kurvenverhalten.
FI890729A0 (fi) Anordning foer montering av delarna i en vinkelremledning.
DE69627279D1 (de) Gelierungsbeschleuniger, einen diesen beinhaltenden Injektionsschlamm und dessen Verwendung
CA2188464A1 (en) Collagen preparation for the controlled release of active substances
ES2113765T3 (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaespiro(4.5)decano-2-propanamina.
FR2700111B1 (fr) Ligament artificiel pour prothèse ligamentaire.
FI904268A0 (fi) Anordning foer arbeten i t.ex. roerledningar.
ES1007520Y (es) Disposicion de inhabilitacion para jeringuillas de un solo uso.
ES1026321Y (es) Anclaje para protesis dental removible.
FR2686244B3 (fr) Ligament artificiel.
AR010620A4 (es) Jeringa autodescartable grima
ES1008972Y (es) Protesis peneana perfeccionada.
FR2744907B1 (fr) Ligament artificiel, notamment pour la cheville
BR7201553U (pt) Disposicao construtiva em artefato para producao de churros
IT8803542A0 (it) Procedimento per la trasformazione dei rifiuti particolarmente rifiuti urbani in sostanze utilizzabili

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118415

Country of ref document: FI

MA Patent expired